▶ 調査レポート

世界のアデノウイルス抗原迅速検査市場(~2028年):血液抗原検査、便抗原検査

• 英文タイトル:Global Adenovirus Antigen Rapid Tests Market Insights, Forecast to 2028

Global Adenovirus Antigen Rapid Tests Market Insights, Forecast to 2028「世界のアデノウイルス抗原迅速検査市場(~2028年):血液抗原検査、便抗原検査」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-16717
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、アデノウイルス抗原迅速検査のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
アデノウイルス抗原迅速検査のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
アデノウイルス抗原迅速検査の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
アデノウイルス抗原迅速検査のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までのアデノウイルス抗原迅速検査の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のアデノウイルス抗原迅速検査の売上および2028年までの予測に焦点を当てています。

アデノウイルス抗原迅速検査のグローバル主要企業には、Biopanda Reagents、CTK Biotech、Creative Diagnostics、Biomerieux、Accuquik、SA Scientific、Diasorin S.P.A、QIAGEN、Quidel Corporationなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

アデノウイルス抗原迅速検査市場は、タイプとアプリケーションによって区分されます。世界のアデノウイルス抗原迅速検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
血液抗原検査、便抗原検査

【アプリケーション別セグメント】
病院、診断実験所、診療所、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- アデノウイルス抗原迅速検査製品概要
- タイプ別市場(血液抗原検査、便抗原検査)
- アプリケーション別市場(病院、診断実験所、診療所、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のアデノウイルス抗原迅速検査販売量予測2017-2028
- 世界のアデノウイルス抗原迅速検査売上予測2017-2028
- アデノウイルス抗原迅速検査の地域別販売量
- アデノウイルス抗原迅速検査の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別アデノウイルス抗原迅速検査販売量
- 主要メーカー別アデノウイルス抗原迅速検査売上
- 主要メーカー別アデノウイルス抗原迅速検査価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(血液抗原検査、便抗原検査)
- アデノウイルス抗原迅速検査のタイプ別販売量
- アデノウイルス抗原迅速検査のタイプ別売上
- アデノウイルス抗原迅速検査のタイプ別価格
・アプリケーション別市場規模(病院、診断実験所、診療所、その他)
- アデノウイルス抗原迅速検査のアプリケーション別販売量
- アデノウイルス抗原迅速検査のアプリケーション別売上
- アデノウイルス抗原迅速検査のアプリケーション別価格
・北米市場
- 北米のアデノウイルス抗原迅速検査市場規模(タイプ別、アプリケーション別)
- 主要国別のアデノウイルス抗原迅速検査市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのアデノウイルス抗原迅速検査市場規模(タイプ別、アプリケーション別)
- 主要国別のアデノウイルス抗原迅速検査市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のアデノウイルス抗原迅速検査市場規模(タイプ別、アプリケーション別)
- 主要国別のアデノウイルス抗原迅速検査市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のアデノウイルス抗原迅速検査市場規模(タイプ別、アプリケーション別)
- 主要国別のアデノウイルス抗原迅速検査市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのアデノウイルス抗原迅速検査市場規模(タイプ別、アプリケーション別)
- 主要国別のアデノウイルス抗原迅速検査市場規模(トルコ、サウジアラビア)
・企業情報
Biopanda Reagents、CTK Biotech、Creative Diagnostics、Biomerieux、Accuquik、SA Scientific、Diasorin S.P.A、QIAGEN、Quidel Corporation
・産業チェーン及び販売チャネル分析
- アデノウイルス抗原迅速検査の産業チェーン分析
- アデノウイルス抗原迅速検査の原材料
- アデノウイルス抗原迅速検査の生産プロセス
- アデノウイルス抗原迅速検査の販売及びマーケティング
- アデノウイルス抗原迅速検査の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- アデノウイルス抗原迅速検査の産業動向
- アデノウイルス抗原迅速検査のマーケットドライバー
- アデノウイルス抗原迅速検査の課題
- アデノウイルス抗原迅速検査の阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Adenovirus Antigen Rapid Tests estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Adenovirus Antigen Rapid Tests is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Adenovirus Antigen Rapid Tests is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Adenovirus Antigen Rapid Tests is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Adenovirus Antigen Rapid Tests include Biopanda Reagents, CTK Biotech, Creative Diagnostics, Biomerieux, Accuquik, SA Scientific, Diasorin S.P.A, QIAGEN and Quidel Corporation, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Adenovirus Antigen Rapid Tests companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Adenovirus Antigen Rapid Tests market. Further, it explains the major drivers and regional dynamics of the global Adenovirus Antigen Rapid Tests market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Biopanda Reagents
CTK Biotech
Creative Diagnostics
Biomerieux
Accuquik
SA Scientific
Diasorin S.P.A
QIAGEN
Quidel Corporation
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Adenovirus Antigen Rapid Tests Segment by Type
Blood Antigen Tests
Stool Antigen Tests
Adenovirus Antigen Rapid Tests Segment by Application
Hospitals
Diagnostic Laboratories
Clinics
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Adenovirus Antigen Rapid Tests market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Adenovirus Antigen Rapid Tests market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Adenovirus Antigen Rapid Tests, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Adenovirus Antigen Rapid Tests, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Adenovirus Antigen Rapid Tests revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Adenovirus Antigen Rapid Tests market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Adenovirus Antigen Rapid Tests revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Biopanda Reagents, CTK Biotech, Creative Diagnostics, Biomerieux, Accuquik, SA Scientific, Diasorin S.P.A, QIAGEN and Quidel Corporation, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Adenovirus Antigen Rapid Tests in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adenovirus Antigen Rapid Tests companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adenovirus Antigen Rapid Tests revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adenovirus Antigen Rapid Tests Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood Antigen Tests
1.2.3 Stool Antigen Tests
1.3 Market by Application
1.3.1 Global Adenovirus Antigen Rapid Tests Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adenovirus Antigen Rapid Tests Market Perspective (2017-2028)
2.2 Adenovirus Antigen Rapid Tests Growth Trends by Region
2.2.1 Adenovirus Antigen Rapid Tests Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Adenovirus Antigen Rapid Tests Historic Market Size by Region (2017-2022)
2.2.3 Adenovirus Antigen Rapid Tests Forecasted Market Size by Region (2023-2028)
2.3 Adenovirus Antigen Rapid Tests Market Dynamics
2.3.1 Adenovirus Antigen Rapid Tests Industry Trends
2.3.2 Adenovirus Antigen Rapid Tests Market Drivers
2.3.3 Adenovirus Antigen Rapid Tests Market Challenges
2.3.4 Adenovirus Antigen Rapid Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adenovirus Antigen Rapid Tests Players by Revenue
3.1.1 Global Top Adenovirus Antigen Rapid Tests Players by Revenue (2017-2022)
3.1.2 Global Adenovirus Antigen Rapid Tests Revenue Market Share by Players (2017-2022)
3.2 Global Adenovirus Antigen Rapid Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adenovirus Antigen Rapid Tests Revenue
3.4 Global Adenovirus Antigen Rapid Tests Market Concentration Ratio
3.4.1 Global Adenovirus Antigen Rapid Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adenovirus Antigen Rapid Tests Revenue in 2021
3.5 Adenovirus Antigen Rapid Tests Key Players Head office and Area Served
3.6 Key Players Adenovirus Antigen Rapid Tests Product Solution and Service
3.7 Date of Enter into Adenovirus Antigen Rapid Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adenovirus Antigen Rapid Tests Breakdown Data by Type
4.1 Global Adenovirus Antigen Rapid Tests Historic Market Size by Type (2017-2022)
4.2 Global Adenovirus Antigen Rapid Tests Forecasted Market Size by Type (2023-2028)
5 Adenovirus Antigen Rapid Tests Breakdown Data by Application
5.1 Global Adenovirus Antigen Rapid Tests Historic Market Size by Application (2017-2022)
5.2 Global Adenovirus Antigen Rapid Tests Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Adenovirus Antigen Rapid Tests Market Size (2017-2028)
6.2 North America Adenovirus Antigen Rapid Tests Market Size by Type
6.2.1 North America Adenovirus Antigen Rapid Tests Market Size by Type (2017-2022)
6.2.2 North America Adenovirus Antigen Rapid Tests Market Size by Type (2023-2028)
6.2.3 North America Adenovirus Antigen Rapid Tests Market Share by Type (2017-2028)
6.3 North America Adenovirus Antigen Rapid Tests Market Size by Application
6.3.1 North America Adenovirus Antigen Rapid Tests Market Size by Application (2017-2022)
6.3.2 North America Adenovirus Antigen Rapid Tests Market Size by Application (2023-2028)
6.3.3 North America Adenovirus Antigen Rapid Tests Market Share by Application (2017-2028)
6.4 North America Adenovirus Antigen Rapid Tests Market Size by Country
6.4.1 North America Adenovirus Antigen Rapid Tests Market Size by Country (2017-2022)
6.4.2 North America Adenovirus Antigen Rapid Tests Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Adenovirus Antigen Rapid Tests Market Size (2017-2028)
7.2 Europe Adenovirus Antigen Rapid Tests Market Size by Type
7.2.1 Europe Adenovirus Antigen Rapid Tests Market Size by Type (2017-2022)
7.2.2 Europe Adenovirus Antigen Rapid Tests Market Size by Type (2023-2028)
7.2.3 Europe Adenovirus Antigen Rapid Tests Market Share by Type (2017-2028)
7.3 Europe Adenovirus Antigen Rapid Tests Market Size by Application
7.3.1 Europe Adenovirus Antigen Rapid Tests Market Size by Application (2017-2022)
7.3.2 Europe Adenovirus Antigen Rapid Tests Market Size by Application (2023-2028)
7.3.3 Europe Adenovirus Antigen Rapid Tests Market Share by Application (2017-2028)
7.4 Europe Adenovirus Antigen Rapid Tests Market Size by Country
7.4.1 Europe Adenovirus Antigen Rapid Tests Market Size by Country (2017-2022)
7.4.2 Europe Adenovirus Antigen Rapid Tests Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adenovirus Antigen Rapid Tests Market Size (2017-2028)
8.2 Asia-Pacific Adenovirus Antigen Rapid Tests Market Size by Type
8.2.1 Asia-Pacific Adenovirus Antigen Rapid Tests Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Adenovirus Antigen Rapid Tests Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Adenovirus Antigen Rapid Tests Market Share by Type (2017-2028)
8.3 Asia-Pacific Adenovirus Antigen Rapid Tests Market Size by Application
8.3.1 Asia-Pacific Adenovirus Antigen Rapid Tests Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Adenovirus Antigen Rapid Tests Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Adenovirus Antigen Rapid Tests Market Share by Application (2017-2028)
8.4 Asia-Pacific Adenovirus Antigen Rapid Tests Market Size by Region
8.4.1 Asia-Pacific Adenovirus Antigen Rapid Tests Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Adenovirus Antigen Rapid Tests Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Adenovirus Antigen Rapid Tests Market Size (2017-2028)
9.2 Latin America Adenovirus Antigen Rapid Tests Market Size by Type
9.2.1 Latin America Adenovirus Antigen Rapid Tests Market Size by Type (2017-2022)
9.2.2 Latin America Adenovirus Antigen Rapid Tests Market Size by Type (2023-2028)
9.2.3 Latin America Adenovirus Antigen Rapid Tests Market Share by Type (2017-2028)
9.3 Latin America Adenovirus Antigen Rapid Tests Market Size by Application
9.3.1 Latin America Adenovirus Antigen Rapid Tests Market Size by Application (2017-2022)
9.3.2 Latin America Adenovirus Antigen Rapid Tests Market Size by Application (2023-2028)
9.3.3 Latin America Adenovirus Antigen Rapid Tests Market Share by Application (2017-2028)
9.4 Latin America Adenovirus Antigen Rapid Tests Market Size by Country
9.4.1 Latin America Adenovirus Antigen Rapid Tests Market Size by Country (2017-2022)
9.4.2 Latin America Adenovirus Antigen Rapid Tests Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adenovirus Antigen Rapid Tests Market Size (2017-2028)
10.2 Middle East & Africa Adenovirus Antigen Rapid Tests Market Size by Type
10.2.1 Middle East & Africa Adenovirus Antigen Rapid Tests Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Adenovirus Antigen Rapid Tests Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Adenovirus Antigen Rapid Tests Market Share by Type (2017-2028)
10.3 Middle East & Africa Adenovirus Antigen Rapid Tests Market Size by Application
10.3.1 Middle East & Africa Adenovirus Antigen Rapid Tests Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Adenovirus Antigen Rapid Tests Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Adenovirus Antigen Rapid Tests Market Share by Application (2017-2028)
10.4 Middle East & Africa Adenovirus Antigen Rapid Tests Market Size by Country
10.4.1 Middle East & Africa Adenovirus Antigen Rapid Tests Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Adenovirus Antigen Rapid Tests Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biopanda Reagents
11.1.1 Biopanda Reagents Company Details
11.1.2 Biopanda Reagents Business Overview
11.1.3 Biopanda Reagents Adenovirus Antigen Rapid Tests Introduction
11.1.4 Biopanda Reagents Revenue in Adenovirus Antigen Rapid Tests Business (2017-2022)
11.1.5 Biopanda Reagents Recent Developments
11.2 CTK Biotech
11.2.1 CTK Biotech Company Details
11.2.2 CTK Biotech Business Overview
11.2.3 CTK Biotech Adenovirus Antigen Rapid Tests Introduction
11.2.4 CTK Biotech Revenue in Adenovirus Antigen Rapid Tests Business (2017-2022)
11.2.5 CTK Biotech Recent Developments
11.3 Creative Diagnostics
11.3.1 Creative Diagnostics Company Details
11.3.2 Creative Diagnostics Business Overview
11.3.3 Creative Diagnostics Adenovirus Antigen Rapid Tests Introduction
11.3.4 Creative Diagnostics Revenue in Adenovirus Antigen Rapid Tests Business (2017-2022)
11.3.5 Creative Diagnostics Recent Developments
11.4 Biomerieux
11.4.1 Biomerieux Company Details
11.4.2 Biomerieux Business Overview
11.4.3 Biomerieux Adenovirus Antigen Rapid Tests Introduction
11.4.4 Biomerieux Revenue in Adenovirus Antigen Rapid Tests Business (2017-2022)
11.4.5 Biomerieux Recent Developments
11.5 Accuquik
11.5.1 Accuquik Company Details
11.5.2 Accuquik Business Overview
11.5.3 Accuquik Adenovirus Antigen Rapid Tests Introduction
11.5.4 Accuquik Revenue in Adenovirus Antigen Rapid Tests Business (2017-2022)
11.5.5 Accuquik Recent Developments
11.6 SA Scientific
11.6.1 SA Scientific Company Details
11.6.2 SA Scientific Business Overview
11.6.3 SA Scientific Adenovirus Antigen Rapid Tests Introduction
11.6.4 SA Scientific Revenue in Adenovirus Antigen Rapid Tests Business (2017-2022)
11.6.5 SA Scientific Recent Developments
11.7 Diasorin S.P.A
11.7.1 Diasorin S.P.A Company Details
11.7.2 Diasorin S.P.A Business Overview
11.7.3 Diasorin S.P.A Adenovirus Antigen Rapid Tests Introduction
11.7.4 Diasorin S.P.A Revenue in Adenovirus Antigen Rapid Tests Business (2017-2022)
11.7.5 Diasorin S.P.A Recent Developments
11.8 QIAGEN
11.8.1 QIAGEN Company Details
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Adenovirus Antigen Rapid Tests Introduction
11.8.4 QIAGEN Revenue in Adenovirus Antigen Rapid Tests Business (2017-2022)
11.8.5 QIAGEN Recent Developments
11.9 Quidel Corporation
11.9.1 Quidel Corporation Company Details
11.9.2 Quidel Corporation Business Overview
11.9.3 Quidel Corporation Adenovirus Antigen Rapid Tests Introduction
11.9.4 Quidel Corporation Revenue in Adenovirus Antigen Rapid Tests Business (2017-2022)
11.9.5 Quidel Corporation Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer